METAGENOMI THERAPEUTICS INC (MGX:NASDAQ)
$1.21 -0.04 (-3.2%)
Analysed METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) News Sources
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
05-03-2026
yahoo.com
Metagenomi Therapeutics: Q4 Earnings Snapshot
05-03-2026
yahoo.com
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates
05-03-2026
yahoo.com
Spotlight On 3 ASX Penny Stocks With Market Caps Under A$2B
02-04-2026
yahoo.com
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
16-04-2026
yahoo.com
Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
11-05-2026
yahoo.com
Metagenomi Therapeutics (MGX) Reports Q1 Loss, Misses Revenue Estimates
12-05-2026
yahoo.com
Metagenomi Therapeutics, Inc. (NASDAQ:MGX) Just Reported And Analysts Have Been Cutting Their Estimates
14-05-2026
yahoo.com
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
28-05-2026
yahoo.com
What is the current price of METAGENOMI THERAPEUTICS INC (MGX:NASDAQ)?
The current price of METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) is $1.21.
METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) since the previous trading day is $-0.04.
METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) since the previous trading day is -3.2%.
What is the most recent average sentiment score for METAGENOMI THERAPEUTICS INC (MGX:NASDAQ)?
The most recent average sentiment score for METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) is 39 out of 100.
What is the most recent average sentiment for METAGENOMI THERAPEUTICS INC (MGX:NASDAQ)?
The most recent sentiment for METAGENOMI THERAPEUTICS INC (MGX:NASDAQ) is .
SEC-8K** Filing Available For METAGENOMI THERAPEUTICS INC (MGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.